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Abstract 
The ancient treatment of dressing infected wounds wi.th honey is rapidly becoming 
re-established in professional medicine, especially where wounds are infected with 
antibiotic-resistant bacteria. This is because ofthe demonstrated sensitivity of such 
bacteria to the antibacterial activity ofhauey, which is not influenced by whether or 
not strains are resistant to antibiotics. Honey has been found to have a very broad 
spectrum of activity, but its potency of antibacterial activity can vary greatly. In most 
honeys the antibacterial activity is due to enzymatically produced hydrogen 
peroxide and thus the potency of its antibacterial activity can be decreased by 
catalase present in an open wound. Manuka honey has an antibacterial component 
derived from the plant source. Manuka honey with a quality-assured level of 
antibacterial activity is being used by companies marketing honey products for 
wound care that are registered with the medical regulatory authorities in various 
countries. Such honey can be diluted IO-fold or more and still completely inhibitthe 
usual wound-infecting species. There is a large amount of clinical evidence for the 
effectiveness of honey in clearing infection in wounds, and some clinical evidence 
of its effectiveness in treating other infections. Although the antibacterial potency 
of honey is insufficient to allow its use systemically, there are various clinical 
applications besides wound care in which it is used topically or where it does not get 
excessively diluted, such as for treatment of gastritis, enteritis, gingivitis, ophthal-
mological infections and bronchial infections. In most of these applications the 
anti-inflammatory activity of honey is of additional benefit in decreasing the 
inflammation resulting from infection. Additional clinical research is needed to 
provide better evidence of the effectiveness of honey in these therapeutic applica-
tions of honey. 
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9.1 
Introduction 
An Editorial in the Journal of the Royal Society afMedicine in 1989 [1], entitled 'Honey ~ 
a remedy rediscovered', expressed the view that 'The therapeutic potential of 
uncontaminated pure honey is grossly under-utilized' and that 'The time has now 
come for conventional medicine to lift the blinds off this "traditional remedy" and 
give it its due recognition'. 'This Editorial noted the many papers being published 
reporting good results when honey was used as a dressing on infected wounds and 
when used in an electrolyte solution in a clinical trial on treatment of diarrhea. In 
many of the published reports on treatment of infected wounds honey was used 
where antibiotics were failing to clear the infection. The rapidly increasing number of 
papers published on the use of honey on wounds in more recent years is probably a 
reflection of the escalation of the problem of bacteria developing resistance to 
antibiotics. It is probably also a reflection of honey becoming available as various 
registered sterile wound-care products, especially ones designed for ease of use [2]. 
This chapter covers the nature and spectrum of the antimicrobial activity of honey, the 
evidence for its clinical effectiveness in clearing infection, and the other beneficial 
therapeutic activities that are seen when honey is used as a topical antimicrobial 
agent. 
9.1.1 
History 
Honey is the oldest medicine knO\vn and in many ancient races of people was 
prescribed by physicians for a wide variety of ailments [3]. The ancient Egyptians, 
Assyrians, Chinese, Greeks and Romans all used honey, in combination with other 
herbs and on its own, to treat wounds and diseases of the gut [4J. Its use for the 
treatment of diarrhea was recommended by the Muslim prophet Mohammed [5]. In 
Ancient Greece, Aristotle [6J wrote of honey being a salve for wounds and sore eyes 
and Dioscorides around 50 AD wrote of honey being 'good for sunburn and spots on 
the face' and 'for all rotten and hollow ulcers' [7]. He also wrote that 'honey heals 
inflammation of the throat and tonsils, and cures coughs'. 
The use of honey as a therapeutic agent has continued into present-day fol1< 
medicine. In India, lotus honey is used to treat eye diseases [8}. Other examples of 
current-day usage of honey in folk medicine are: as a traditional therapy for infected 
leg ulcers in Ghana [9], as a traditional therapy for earache in Nigeria [10], and as a 
traditional therapy in Mali for the topical treatment of measles and in the eyes in 
measles to prevent corneal scarring [11]. Honey also has a traditional folklore usage 
for the treatment of gastric ulcers [12J and its ancient usage to treat sore throats has 
continued into the traditional medi.cine of modern times [13]. 
However, many medical professionals are ofthe opinion that honey has no place in 
modern medicine. An Editorial in Archives afInternal Medicine assigned honey to the 
category of 'worthless but halUlless substances' [14] and Editorials in other medical 
journals have clearly shown a lack of awareness of the research tbat has demonstrated 
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the rational explanations fDrthe therapeutic effects of haney [15, 16J. Manyphysicians 
are not even aware that honey has an antibacterial activity beyond the osmotic effect of 
its sugar content p 6~23], yet there have been numerous publications over the past 70 
years reporting that there are other components of honey that have a much more 
potent antimicrobial effect. 
The first indication that the antimicrobial activity of honey was not just an osmotic 
effect was in a report by Sackett [24] who observed that the antibacterial potency was 
increased by limited dilution of honey - an observation that was hard to explain. More 
intensive study two decades later by Dold et al. [25] led to the discovery of an 
antibacterial factor which they termed 'inhibine' - a term widely used in the literature 
for the next 26 years until the antibacterial factor was identified as hydrogen peroxide 
by Wnite et al. [26]. The term 'inhibine number' was also used, this being the number 
of dilution steps a honey could be subjected to and still. have antibacterial activity. 
Subsequent studies have found that where a range of honeys has been tested against a 
single species of microorganism the minimum inhibitory concentration (MIC) of 
honey varied widely: 25-0.25 % [27], greater than 50-1.5 [281, 20-0.6 [29] and 
50-1.5% Iv Iv) [30]. 
111is discovery by microbiologists studying honey that different honeys varied 
markedly in their antimicrobial potency is in effect probably a rediscovery of ancient 
-..visdorn. The ancient physicians who prescribed honey for various ailments would 
have had no knowledge of the principles involved in its medicinal action, just an 
empirical knowledge gained from its effective usage. However, they were aware that 
some honeys were better others for medical usage: Dioscorid.es around 50 AD stated 
that a pale yenow honey from Attica was the best, being 'good for an rotten and. hollow 
ulcers' [7J; and Aristotle [6J, discussing differences in honeys, referred to pale honey 
being 'good as a salve for sore eyes and wounds'. Present-day folk medicine also 
recognizes differences in honeys: the strawberry-tree honey of Sardinia is valued for 
its therapeutic properties [31J; in India, lotus honey is said to be a panacea for eye 
diseases [8]; honey from the Jirdin valley of Yemen is highly valued in Dubai for its 
therapeutic properties [32J; manuka honey has a long-standing reputation in New 
Zealand folldore for its antiseptic properties (K. Simpson, personal communication). 
This knowledge that honey is not a 'generic medicine' but needs appropriate 
selection for therapeutic use is not -..videspread, so until recently most clinical 
treatment and miCTobiological studies have been done with honey vvith an unknown 
level of antimicrobial activity. 
9.2 
Nature of the Antimicrobial Activity of Honey 
9.2.1 
High Osmolarity 
The osmolarity of honey alone is sufficient to prevent microbial growth. Granulated 
honey is a saturated solution of sugars and clear honey is a supersaturated solution. 
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Although honey with a high water content can spoil because some oS:Q1ophilic yeasts 
can live in it, no fermentation occurs if the water content is below 17,1% [33], The 
water content of honey is usually 15-21% by weight [34], Of the solids in honey, 84% 
is comprised of the monosaccharides fructose and glucose [35J, The strong interac-
tion of these sugar molecules with water molecules leaves very few of the water 
molerules available for microorganisms. The water molecules that are 'free' water are 
measured as the water activity (aw), The mean values of aw for honey have been 
reported as 0.562 and 0.589 [36], 0.572 and 0.607 [37], and 0.62 [38]. Many species of 
bacteria have their grov.rth completely inhibited by the aw being in the range 
0,94-0,99 [39, 40]. Calculated on the basis of the concentration being proportional 
to -logaw, these inhibitory values of aw correspond to solutions of a typical honey 
(with"w of 0.6) of concentrations from 12 down to 2% (v/v) [40]. Fungi are generally 
much more tolerant than bacteria of low aw [39J. Staphylococcus aureus has an 
exceptionally high tolerance onow aw: for complete inhibition of growth of S. aureus 
the aw has to be lowered below 0.86 [39,41,42], which would be a typical honey at 
29% (vjv). There have been many reports of granulated sugar being used as a wound 
dressing [43J, but it has been reported that infection is not cleared or new infection 
becomes established in cases where urine or heavy exudate from wounds dilutes the 
sugar [44J, With honey, the presence of other antimicrobial factors allows it to be 
inhibitory even when diluted down to an osmolarity tha.t will freely allow grovvth of 
microorganisms, With a honey that has a. median level of antibacterial activity it is 
possible to have it diluted to as Iowa concentration as 2% (v jv) and still have it 
completely inhibit the gruwth of S, aureus [45], In a study of methicillin-resistant 
S. aureus (MRSA) [46] with honeys that had near median levels of antibacterial 
potency it was found that whereas the MIC of the honeys for any of the strains was 
below 4% (vjv), the M1C for a s)'1up of a mixture of sugars at the concentrations that 
occur in honey was above 30% (vjv). Similar studies vvith coagulase-negative 
staphylococci [47], Burkholderia cepacia [48J, enterococci [46J and Pseudomonas 
spp. [49] found MIC values for the honeys of 3-5, 2.1-5, 3.83-9.66 and 
4.33-·9.0%, respectively, whereas the MJC for the syrup was 27.5-31.7, 17.5-22, 
27.7-29.8 and 17-22%, respectively. 
9.2.2 
Acidity 
The antibacterial activity of honey is part1y due also to acidity. Honey is character-
istically of a pH between 3.2 and 4.5 [34]. This acidity is due primarily to honey 
containing 0.23-0.98% (1.8-7.5 mmol/kg) gluconolactone/gluconic acid [35], 
which is formed by the action of the enzyme glucose oxidase which bees add to 
the nectar they coneet to make honey. However, no correlation has been found 
between antibacterial activity and the pH of the honey when this has been 
studied [37, 50-54]. This may be because of different degrees of buffering in 
different honeys: the pH does not necessarily indicate the titratable acidity, but it is 
the titratable acidity that determines the final pH when honey is diluted by a 
neutralizing solution. With such a low concentration of acid in honey there is not 
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much lowering of the pH when honey is added to culture media or serum. In work 
with S. aureus no inhibition was seen with gluconic acid added to nutrient broth at 
levels up to 0.25% [55]. However, in a study with Corynebacterium diphtheriae the 
MIC of the honey used was found to be 4.5%, but was 10% when the honey was 
neutralized [56J. The pH of the nutrient broth containing honey at 4.5% was 
measured and found to be 6.2. The acidity of honey was found to be of effect in the 
inhibition of BaciUus cereus also: inhibition by 50% honey in an agar diffusion assay 
was lost if phosphate buffer was added to bring the pH to 6.1-6.5 [571. The low pH 
of honey that has not been too much diluted by a neutralizing medium would be 
at least partially inhibitory to many animal pathogens. The optimum pH for grovvth 
of these pathogens is normally between 7.2 and 7.4, although the minimum pH 
values for growth of some common wound-infecting species are: Escherichia coli, 
4.3; Salmonella species, 4.0; Pseudomonas aeruginosa, 4.4; Streptococcus pyogenes, 
4.5 [58]. The concentration of bicarbonate (the principle buffering ion) in the 
extracellular fluid of the body is 25 mmol/l, so the dilution of a honey containing a 
median level of gluconolactone/gluconic acid with an equal volume of extracellular 
fluid would raise the pH of the honey to 6.8. This means that where honey gets diluted 
by body fluid the aci.dity of honey mal<es a minor contribution to antibacterial activity 
and it is the other ant5bacterial components that are primarily responsible for control 
of infection when honey is used therapeutically. 
9.2.3 
Hydrogen Peroxide 
Hydrogen peroxide is the major antimicrobial factor in most honeys. Adcock [59J 
found that the antibacterial activity of honey could be removed by the addition of 
catalase (which catalyzes the destruction of hydrogen peroxide), and White eta/. [26] 
demonstrated a direct relationship between the hydrogen peroxide produced and 
the 'inhibine number' of various honeys. The hydrogen peroxide in honey is 
produced by the action of the enzyme glucose oxidase, which is secreted into 
collected nectar from the hypopharyngeal gland of the bees. A similar type of 
antimicrobial system was discovered when Fleming's work on the antibacterial 
properties of Penicillium notatum was followed up by Coulthard ef. al. [55]. They 
traced the cause of the erratic results they were obtaining to the potent activity of a 
second factor, notatin, which was present in addition to penicillin. They found 
notatlu to he a combination of the enzyme glucose oxidase with glucose, and 
showed the activity of nota tin to be due to the hydrogen peroxide produced. Oxygen 
needs to be available for the reaction: 
H H 
HO 
HO '-\..;.;,.~_"" 
o 
H OH H 
~-D-glucose + oxygen __ o-gluconolactone + hydrogen peroxide 
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This means that that this antimicrobial activity from honey can only be of use 
under aerobic conditions. The production of hydrogen peroxide durirfg the ripening 
of honey serves to sterilize the honey stored in the comb, but undiluted honey has a 
negligible level of hydrogen peroxide [26,60,61]. 
Glucose oxidase is practically inactive in full· strength honey, it giving rise to 
hydrogen peroxide only when the honey is diluted [26]. One explanation for this is 
that the activity of the enzyme is suppressed by the low pH in ripened honey. The 
enzyme has an optimum pH of 6.1, with a good activity from pH 5.5 to 8, but the 
activity drops off sharply below pH 5.5 to near 0 at pH 4 [62]. It is not a case of 
substrate inhibition of the enzyme, as glucose concentrations beyond those occur-
ring in honey do not suppress the rate of reaction, the optimum substrate concen-
tration for the glucose oxidase in honey being exceptionally high (1.5 mol/I) [62]. This 
high optimum concentration is well suited to the enzyme's functioning in ripening 
honey (the concentration of glucose in ripened honey being around 2 mol/I), but will 
markedly limit the rate of production of hydrogen peroxide in well-diluted honey. The 
need to dilute honey to get the enzyme active is most likely because of the low water 
activity of honey, as it is lmown that enzymes need a sufficiently high water activity to 
be active [63J. As honey is diluted the activity of glucose oxidase increases to a peak at a 
concentration around 30~50% (v/v) honey as the water activity is increased, then falls 
again as the enzyme and substrate concentrations are decreased by further dilu· 
tion [64J. Honey solutions were found to maintain at least half of the maximum rate of 
generation of hydrogen peroxide over a wide range of dilution that is concentrations 
of honey from approximately 15 to 67% (v/v) [641. 
Inhibition of the enzyme by high concentrations of honey is not caused by either of 
the products of the reaction. In a system buffered to prevent inhibition of the enzyme 
by low pH, no inhibition at all was seen with 10 mmol/l gluconic acid or glucono· 
lactone [62]. Nor does hydrogen peroxide cause inhibition at the levels that are 
produced in honey [65]. However, studies with honey [261 and with the isolated 
enzyme [65J found the rate of reaction to be falling off over a short period of time. 
Adding ascorbic acid to remove the hydrogen peroxide as it was produced gave a 
fivefold increase in the rate of reaction [65]. Bang et 'al. [64] found that when 50% 
solutions of honey were incubated, hydrogen peroxide accumu1ated to a peak level 
then the concentration of hydrogen peroxide dropped, it becoming zero after 
24-48 h. This is' probabl.y the result of damage to the enzyme by accumu1ated 
hydrogen peroxide, as it has been reported ~at addition of 68 mmol/l hydrogen 
peroxide to glucose oxidase isolated from honey caused a significant decline in the 
enzyme's rate of reaction after 20 min [65]. Whilst this means that honey does not 
have prolonged antimicrobial activity once it has been diluted, it does have the 
advantage of preventing hydrogen peroxide from accumulating to levels that are 
harmful to body tissues. The maximum concentration of hydrogen peroxide achieved 
when a 50% (v Iv) solution of a honey with a high level of antibacterial activity was 
incubated was found to be 3.65 mmol/l [64], which is 242-fold lower than the 3% 
(882 mmol/l) solution of hydrogen peroxide typically used as an antiseptic [661. The 
use of hydrogen peroxide as an antiseptic has been discouraged because it is 
cytotoxic [67], but at the low levels that form in honey this is not a problem. Hydrogen 
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peroxide has gone out of common use as an antiseptic also because it causes 
inflammation, but the antioxidant content of honey would help prevent inflamma-
tion being caused, as it has been found that it oxidative species formed from hydrogen 
peroxide, rather than hydrogen peroxide itself, that are responsible for the activation 
of the transcription factor NF-KB involved in the inflammatory response in leuko-
cytes [68J. This activation can be prevented by antioxidants [69]. 
Although only low levels of hydrogen peroxide accumulate in diluted honey, this is 
stin an effective antimicrobial system because of its continuous production. Hydro-
gen peroxide has been found to be more effective when supplied by continuous 
generation by glucose oxidase than when added as a bolus [70]. E. coli exposed to a 
constantly replenished stream of hydrogen peroxide had their growth inhibited by as 
little as 0.02-0.05 mmol/lhydrogen peroxide, a concentration that was not damaging 
to fibroblast cells from human skin [71]. Rates of production of hydrogen peroxide in 
diluted honey that have been reported are: 2.2-5.6 mmol/I/h for 30% (v Iv) solutions 
of eight honeys (three of them blends of 20-30 samples of individual honeys) [64], 
0-2.12 mmol/l/h for 14% (v/v) solutions of90 samples of honey [61], 0-4.8 mmol/l/h 
for 20% (v/v) solutions of 37 samples of honey [721 and 0.10-0.58mmollllh for 
36% (v Iv) solutions of25 samples of honey [59]. 
Quite low levels of hydrogen peroxide are required for antibacterial activity. It has 
been reported that S. aureus failed to grow in 24 h in nutrient broth containing 
hydrogen peroxide at 0.29 mmol/!, but grew at 0.15 mmolll [55]. In other work with 
S. aureus the 20% inhibition of growth over an incubation period of 16 h that was 
observed corresponded vrith an accumulation of 0.12 mmol/l hydrogen peroxide 
from the glucose oxidase-glucose system used to generate it [72]. Others found 
growth of only one colony of S. aureus on a nutrient agar plate containing 0.29 romol/1 
hydrogen peroxide and none at the next level tested, 0.5 mmo1/l [26]. 
The level of hydrogen peroxide achieved in diluted honey varies from sample to 
sample. It can be related to the floral source, as components from some floral sources 
can affect the enzyme activity that gives rise to hydrogen peroxide and others affect 
the destruction of hydrogen peroxide. The level of hydrogen peroxide achieved is the 
result of there being a dynamic equilibrium betvveen the rate of its production and the 
rate ofits destruction [61]. Hydrogen peroxide has been found to rapidly disappear 
when added to dilute honey [61]. Catalase, an enzyme that destroys hydrogen 
peroxide, has been shown to be present in honey [73J, it coming from the pollen 
and nectar of certain plants, more from the nectar [74]. Honeys from some floral 
sources have been found to have very high levels of catalase activity and these 
accumuJate low levels of hydrogen peroxide, whereas those vvith low levels of catalase 
activity accumulate high levels of hydrogen peroxide [28, 74J. However, it has been 
found that hydrogen peroxide disappears when added to honey even ifhoneyis boiled 
beforehand to inactivate catalase, indicating that loss though chemical reaction is 
involved as well as Uu'ough enzymic desnuction [26]. Variation between honeys 
occurs also in the rate of production of hydrogen peroxide. Extraction of honey from 
the combs and processing to remove wax and other particles requires the honey to be 
heated. Very large differences have been found betvveen honeys from different floral 
sources in the thermal stability of the glucose oxidase in them [75] and in the 
, 
2361 9 Honey: Antimicrobial Actions and Role in Disease Management 
sensitivity of glucose oxidase to denaturation by light [76]. Thus, the rate of produc-
tion of hydrogen peroxide will depend on the exposure of honey to heat and light, 
particularly daylight and the light from fluorescent tubes [61 j, in its processing and 
storage, as well as it depending on the floral source of the honey. 
9.2.4 
Additional Antibacterial Factors 
In some honeys there are antimicrobial factors additional to osmolarity, acidity and 
production of hydrogen peroxide. Reports of antibacterial activity in honey that is 
stable to heating wen in excess of the variation in stability of glucose oxidase indicates 
that hydrogen peroxide is not the only antibacterial factor in diluted honey. In a study 
of some Jamaican honeys, the activity of-the wo most active honeys was not reduced 
by steam steilizing, whereas in the others it was reduced or destroyed [77J. Conifer 
honeydew honey, with exceptionally high activity, was reported to contain a heat-
stable as well as a heat-sensitive antibacterial factor [50J. More direct evidence for the 
existence of antibacterial factors additional to hydrogen peroxide is seen in reports of 
activity persisting in honeys treated with catalase to remove the hydrogen peroxide 
activity [57, 59, 72, 78-82]. In one of these studies where substantial antibacterial 
activity remained it was shown by direct assay of the level of hydrogen peroxide 
present that the catalase had been completely effective [59J. Lysozyme has been 
identified in honey, usually occurring at a level of 5-10 )..lgjml, occasionally at 
35-100 )..lgjml if the honey is freshly extracted from the comb, but at much lower 
levels in older samples [83]. The flavonoid pinocembrin has been identified as an 
antibacterial component of honey, but at a level only 1-2% of what would be required 
to account for the observed activity not due to hydrogen peroxide [72]. Some phenolic 
acid components of manuka (Leptospermum scoparium) honey with antibacterial 
activity have been identified: 3,5-dimethoxy-4-hydroxybenzoic acid (syringic acid), 
methyl 3,S-dimethoxy-4-hydroxybenzoate (methyl syringate) and 3.4,S-trimethoxy-
benzoic acid [84], but these were later found to account for no more than 4% of the 
antibacterial activity of diluted honey not due to hydrogen peroxide [85]. In viper's 
bugloss (Echium vulgare) honey this type of activity was accounted for entirely by its 
content of 1,4-dihydroxybenzene [85J, but the activity was very low compared with 
that of manuka honey f78]. 
9.2.5 
Manuka Honey 
Manuka honey, produced in l.arge quantities in New Zealand, is very unusual in 
having a high level of antibacterial activity after addition of catalase to destroy 
hydrogen peroxide, sufficient catalase being added to remove hydrogen peroxide 
ata level 100 times higher than that with activity equivalent to the most active honey in 
the study [80]. The possibility was investigated that the activity remaining in manuka 
honey after the addition of catalase was the result of a component of this honey 
inhibiting the enzyme, but it was shovm thatinhibltion did not occur [78]. Tnis Iype of 
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Figure 9.1 Illustration of the rapidity of the breakdown of 
hydrogen peroxide (to oxygen and water) when it is exposed to the 
catalase activity in a small drop of blood on a pricked finger. 
antibacterial activity is significant for clinical applications because all cells of the body 
contain the enzyme catalase, so at least part of the antibacterial activity of other types 
of honey wiI! be destroyed if the honey comes in contact with cens. As hydrogen 
peroxide freely diffuses across cell membranes this breakdown can be quite rapid, as 
is illustrated in Figure 9.1, where a drop of 3% hydrogen peroxide solution has been 
placed on a pricked finger. There will not be complete breakdow11 of hydrogen 
peroxide because the enzyme will act more slowly as the concentration of its substrate 
decreases, so eventually there will be an equilibrium level reached where the rate of 
production equals the rate of destruction. Thus, although both types of antibacterial 
activity in assays in agar or broth may appear to be of similar potency, where the honey 
is exposed to catalase activity in or on the body the activity of other honeys will be less 
than that of manuka honey. Also, the unusual antibacterial activity in manuka honey 
is fully effective in undiluted honey, whereas other types of honey need dilution 
before glucose oxidase becomes active and production of hydrogen peroxide begins. 
Figure 9.2 shows an illustration of this difference, where wound dressings were 
prepared from a manuka honey and a clover honey, each with the same level of 
antibacterial activity when compared as 25% solutions in an agar wen diffusion assay. 
Placing the pieces of dressing against the cut edge of the agal' gel seeded with 
S. aureus simulates the situation where honey dressings are placed on an infected 
open wound. It can be seen that antjbacterial activity has diffused deeply into the agar 
from the manuka honey, but very little antibacterial activity has been produced in the 
clover honey as there has been little dilution to activate the glucose oxidase enzyme to 
produce hydrogen peroxide. It is for these reasons that companies marketing honey 
products for wound care that are registered with the medical regulatory authorities in 
Australia, Canada, the European Union, Hong Kong, New Zealand and the United 
States have chosen to use manuka honey or the equivalent honey produced from 
other Leptospennum species in Australia. 
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Figure 9.2 Model of honey dressings on an infected wound. 
One dressing pad was impregnated with manuka honey, the other 
with dover honey. 
Each honey had the same level of antibacterial activity in an agar well diffusion 
assay. They were placed against the cut edge at each and of the agar which had been 
seeded with S. aureus, then the plate was incubated at 37"C for 18h. 
9.3 
Spectrum and Potency of the Antimicrobial Activity of Honey 
There have been many reports published on the sensitivity of a wide range of species 
of bacteria and fungi to honey. However, in much of this work only a single 
concentration of honey has been used. Sometimes this concentration has been high 
enough for the inhibition of microbial growth that has been observed to have 
probably been due just to the osmotic effect of the honey. Also, with much of the 
published research, even where MIC values for honey are reported the honey has 
been arbitrarily chosen, so its antimicrobial potency relative to that of other honey is 
not knovvn. As mentioned above, the MIC has been found to vary up to IOO-fold 
between different honeys, which means that much of the published d.ata is not a 
useful indication of the results that could be expected with other honey jf the use of 
honey for infection control is being considered. A review of all the research on the 
antimicrobial activity of honey published up to 1992 is available [86,87] for anyone 
wanting to see the scope of this. 
In the present chapter only the findings reported which give information useful for 
making clinical decisions will be covered. Thus, data are presented which are either 
the range ofMIC values found where numerous different honeys were tested or are 
the MIC values where the honey used in the research was selected to have a near-
median level of antibacterial activity. The antibacterial potency of these selected 
honeys has been rated against phenol as a standard antibacterial substance, using an 
agar well diffusion assay with a standard strain of S. aureus [78J. Many companies 
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Table 9.1 M ICs of honeys, for various species of bacteria, reported 
in studies where numerous different honeys were used. 
-"-~---""" 
No. of Mean MIC 
samples Species (% v/v) SD Reference 
60 Staphylococcus aureus 21.6 28.1 [29] 
22 Salmonella typhi H901 4.2 6.1 [27] 
Escherichia coli 4.1 5.5 
Shigella jlexneri Type I 1.4 2.1 
Proteus morganii 6.0 5.7 
Staphylococcus aureus Oxford 209 7.9 9.0 
Bacillus anthracis 10.2 10.7 
27 Staphylococcus aul'eus 5.6 5.0 [30] 
Streptococcus pyogwes Group A 6.1 5.2 
Streptococcus iX"haemolyticus 10.6 6.2 
Corynebacterium diphtheriae 17.7 10.2 
Escherichia coli 40.7 20.4 
Proteus vulgaris 57.0 10.7 
Pseudomonas pyocyanea 28.3 19.6 
Klebsiella pneumoniae 30.4 19.9 
Shigella flexneri 21.4 17.5 
BaciUus anthracis 16.6 19.6 
BaciUus mesentaicus 27.4 24.1 
Monilia albiwlts 60.0 0.0 
18 Staphylococcus aureus ATCC 6538 12.7 1.5 [88] 
42 Bacillus subtilis ATCC 6633 27.8 10.8 [89] 
Escherichia coli ATCC 14948 22.8 11.2 
---------
marketing honey for use as an antibacterial agent are now rating the activity of their 
honeys in the same way, which allows prediction of their likely clinical effectiveness 
by reference to the published research findings. The findings from research with 
numerous samples of honey are summarized in Table 9.1 and those from research 
using standardized honey are summarized in Tabl.e 9.2. The data in Table 9.1 will be 
less representative than that in Table 9.2 of honey in general, as the studies that are in 
Table 9.2 have selected honeys that have antimicrobial potency that is near the median 
level found for honey in a survey of 345 samples of honey, from 26 different floral 
sources [78]. In studies with smaller numbers of samples the activity of the honeys 
used may have been unusually low or unusually high. 
The failure to take into account the large variance in antibacterial potency of 
different honeys may explain some of the large differences in results reported 
betvveen hospitals using honey in similar ways. Some have reported rapid clearance 
of infection in a range of different types of wound, with wounds all becoming sterile 
in 3~6 [98. 99J, 7 [100~102] or 7-10 days [1031. Others have reported bacteria still 
present in wounds after 2 [104. 1051. 3 1106~1081 and 5 weeks [1091. 
\Vhere antibiotic-resistant strains of bacteria have been studied, their sensitivity to 
honey has been found to be essentially the same as that of the antibiotic-sensitive 
strains of the same species [46, 47, 94J. This and the very broad spectrum of 
1239 
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Table 9.2 MICs of honeys for various species of bacteria and fungi, 
reported in studies where honeys with standardized antibacterial 
activity were used. 
No. of 
strains Species of microorganism 
Mean MIC 
(%v/v) 
Manuka honey: nonperoxide activity equivalent to 13.2% phenol 
1 Escherichia coli 3.7 
Proteus ;nimbilis 
Pseudomonas aeruginosa 
Salmonella typhimurium 
Sermtia. marcescen.s 
Staphylococcus aureus 
Streptocon:us pyogene.s 
7.3 
10.8 
6 
6.3 
1.8 
3.6 
Rewarewa honey: hydrogen peroxide activity equivalent to 21.5% phenol 
] Escherichia. coli 7.1 
Proteus ;nimbi/is 
Pseudomonas aeruginosa 
Satnwndla typhimurium 
Serratia. marcescms 
Staphylococcus aureus 
Streptococcus pyogen.e.s 
Manuka honey: nonperoxide activity equivalent to 13.2% phenol 
3.3 
6.8 
4.1 
4.7 
4.9 
2.6 
7 ~le1icobacter pylori 5 
Manuka honey: nonperoxide activity equivalent to 13.2% phenol 
1 Epidermophyton floccosum 10 
Microspomm canis 25 
Microspomm gypseum 50 
Trichophyton mentagrophytes var. interdigitale 25 
Tri,chophyton mentagrophytes var. mentagrophytes 20 
Trichophyton rub rum 1. 0 
Trichophyton tonsurans 25 
Pasture honey: hydrogen peroxide activity equivaJent to 14.8% phenol 
1 Epidennophyton. floccosum 10 
Micro~pornm canis 15 
Microsporum gypseum 20 
Trichophyton mentagrophytes var, interdigitale ] 5 
Trichophyton mentagrophytes var. mentagl'Opitytes 15 
Trichophyton ru,brum 5 
Trichophyton tonsurans 20 
Manuka honey: nonperoxide activity equivalent to 13.2% phenol 
1 Actinomyces pyogenes 
Klebsiella pneumoniae 1.0 
Nocardia. asteroides 
Staphylococcus aureus 
Streptococcus agaladiae 
Streptococcus dysgalactiae 
Streptococcus uberis 
5 
5 
5 
SD Reference 
[90] 
[90] 
[91] 
o 
[92J 
[92J 
[93] 
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Table 9.2 (Continued) 
No. of 
strains Species of microorganism 
Mean MIC 
(% v/v) 
Rewarewa honey: hydrogen peroxide activity equivalent to 21.5% phenol 
1 Actinomyces pyogenes 5 
Klebsiella pneumoniae 10 
Nocardia asieroides 10 
Staphylococcus aureus 5 
Streptococcus agalactiae 10 
Streptococcus dysgalactiae 10 
Streptococcus uberis 10 
Manuka honey: nonperoxide activity equivalent to 13.2% phenol 
1 Enterococw.s faecaLis 7 
Escherichia coli 5 
Klebsiella oxytoca 5 
Pseudomonas aernginosa 
Staphylococcus aureus 
MRSA 
Staphylococcus aureus NCTC6571 
Escherichia coIL NCTC10418 
6 
3 
3 
3 
4 
Pasj~.1.re honey: hydrogen peroxide activity equivalent t.o 14.8% phenol 
1 Enterococcus faecalis 9 
1 E.scherichia coli 9 
Klebsiella oxytoca 8 
Pseudomonas aernginosa 9 
StaphyLococcus aureus 5 
MRSA 4 
Staphylococcus aureus NCTC6571 3 
Escherichia coli NCTC10418 7 
Manuka honey: nonperoxide activity equivalent to 13.2% phenol 
20 Pseudomonas spp. from wounds 6.9 
Pasture honey: hydrogen peroxide activity equivalent to 14.8% phenol 
20 Pseudomonas spp. from wounds 7.1 
Manub. honey: non peroxide activity equivalent to 13.2% phenol 
58 Staphyfococcus au-reus from wounds 2.88 
St:aphylococcus aureus NCTC6571 2,89 
Pasture honey: hydrogen peroxide activity equivalent to 14.8% phenol 
58 Staphylococcus aureus from wounds 3.79 
Sfaphylococcus aureus NCTC6571 3.41 
Manuka honey: nonperoxide activity equivalent to 13.2% phenol 
20 Burkho!deria cepada (multiresistant) 2.9 
Pasture honey: hydrogen peroxide activity equivalent to 14.8% phenol 
20 Burkholderia cepacia (multiresistant) 3.6 
SD Reference 
[93] 
[94[ 
[94] 
{95] 
1.3 
[951 
1.0 
[45J 
0.15 
[45J 
0.25 
[48} 
0.94 
[48J 
0.77 
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Table 9.2 (Continued) 
No. of 
strains Species of microorganism 
Manuka honey: nonperoxide activity equivalent to 18% phenol 
18 MRSA 
7 VSE (Enterococcusfaecalis) 
VRE (Enterococcus avium) 
3 VRE (Enterococcus JaecaUs) 
15 VRE (Enterococcusfaeciurn) 
VRE (En~erococcus raffinosus) 
Mean MIC 
(% v/v) 
2.98 
4.92 
3.83 
4.59 
4.72 
4.86 
Pasture honey: hydrogen peroxide activity equivalent to 13.7% phenol 
18 MRSA 3.07 
7 VSE (En.terococcus faeca.ris) 9.66 
1 VRE (Enterococcus avium) 5.6 
3 VRE (Enterococcusfaeca/is) 9.43 
15 VRE (Enterococcusfaecium) 8.33 
VRE (Enterococcus raffinosu$) 9.0 
Manuka honey: nonperoxide activity equivalent to 18% phenol 
17 Pseudomonas spp. from bums 9.71 
Pasture honey: hydrogen peroxide activity equivalent to 14.8% phenol 
17 Pseudomonas spp. from burns 9.0 
Manuka honey: nonperoxide activity equivalent to 16.8% phenol 
2 Staphylococcus capil-is 3.3 
11 StaphylococcU', epidennidis 3.5 
3 Staphylococcus haemolyticus 3.3 
Staph.yLococcus simulans 3 
Staphylococcus warnen. 3.3 
Pashtre honey: hydrogen peroxide activity equivalent to 17.5% phenol 
2 Staphylococcus capitis 3.8 
11 Staphylococcus epidennidis 3.3 
3 Staphylococcus haemolyticus 4.2 
Staphylococcus simulans 4 
Staphylococcus wameri 3.5 
Manuka honey: nonperoxide activity equivalent to 218% phenol 
18 Candida albicans 39.9 
10 Candida glabrata 42.6 
10 Candida dubliniensis 33.4 
Medihoney (blend): nonperoxide activity equivalent to 218% phenol 
18 Candida albicans 38.2 
10 
10 
Candida glabrata 
Candida dubliniensis 
43.1 
34.6 
Jarrah honey: hydrogen peroxide activity equivalent to 30.2% phenol 
18 Candida alhicuns 18.5 
10 
10 
Candida glabrata 
Candida dubtiniensis 
29.9 
15.4 
SD Reference 
[46] 
0.14 
0.28 
0.52 
0.22 
[46] 
0.26 
0.46 
0.21 
0.52 
[49] 
0.69 
[49] 
1.22 
[47] 
0.5 
0.5 
0.7 
[47] 
0.6 
0.6 
0.8 
[96] 
1.7 
2.7 
2.5 
[96] 
2.9 
4.2 
2.5 
[96] 
2.7 
2.8 
2.8 
Table 9.2 (Continued) 
No. of 
strains Species of microorganism 
Manuka honey: nonperoxide activity equivalent to 15% phenol 
1 Actinobacillus actinomycetemcomitans NCTC 9709 
Actinomyces gerencseriae ATCC 233860 
1 Actinomyces naeslundii NCTC 10301 
EikeneUa cOlTodins ATCC 23834 
Fusobacterium nucleatum ATCC 25586 
Peptostreptococcus micros ATCC 33270 1 
1 
1 
Porphyromonas gingivalis ATCC 33277 
Vei!londta parvula ATCC 17745 
Candida albicans ATCC 10261 
Candida glabrata CBS 138 
Mean MIC 
(% v/v) 
6.1 
7 
9.1 
4.7 
5.1 
9 
6.2 
7.2 
21.5 
40 
Pa..<;ture honey: hydrogen peroxide activity equivalent to 18.2% phenol 
1 Actinobacillus actinomycetemcomitans NCTC 9709 4.8 
Actinomyces gerencseriae A'TCC 233860 9 
Actinomyces naes[undii NCTC 10301 4 
1 Eikmella corrodins ATCC 23834 5.8 
1 Fusobacterium nucIeatum ATCC 25586 6.7 
Peptostreptococcus micros ATCC 33270 9.3 
1 Porphyromonas gingivaUs ATCC 33277 9 
Veillonella parvula ATCC 17745 7 
Candida albicans ATCC 10261 40 
1 Candida glabrata CBS 138 40 
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SD Reference 
[97) 
[97] 
The level of antibacterial activi,ty of the honeys used is expressed as the concentration of phenol, 
w/v, with equivalent activity against s. aureus ATCC 25923 in an agar well diffusion assay. For the 
manuka honeys this was determined with catalase added to destroy hydrogen peroxide. so the 
antibacterial activity is recorded as 'nonperoxide'. MRSA = methicillin-resistant S. aureus; 
VRE = vancomycin-resistant enterococci; VSE = vancomycin-sensitive enterococci. 
antimicrobial activity of honey are features that malce honey very convenient for 
clinical use as a topical agent to control infections. as it is not necessary to first identify 
the infecting species. nor to find the sensitivity of the microorganisms to antibiotics, 
before effective treatment can be given. 
9.4 
Other Actions 
The clearance ofinfeciion by honey may involve more than the antibacterial activity of 
honey, as research findings with leukocytes in cell culture indicate that honey may 
work also by stimulating the activity of the immune system. Peripheral blood B 
lymphocytes and T lymphocytes in cell culture have been f01illd to be stimulated to 
proliferate by honey at concentrations as low as 0.1 % [110}. This low concentration of 
honey was also found to activate phagocytes isolated from blood [110]. Others have 
, 
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reported that honey at a concentration of 1 % stimulates monocytes in cen culture to 
release the cytokines tumor necrosis factor-a, interleukin-lp and interleukin-6 which 
are intermediates in the immune response [111, 112]. Honey has the potential to 
further augment the immune response by supplying glucose, which is essential for 
the 'respiratory burst' in macrophages. Tne hydrogen peroxide thus generated is the 
major component of the bacteria-destroying activity of these cells [113]. The func-
tioning of macrophages would be further aided by the supply of sugars from honey as 
these would provide substrates for glycolysis, which is the major mechanism for 
energy production in these cells. This would allow macrophages to function in 
damaged tissues and exudates where the poor oxygen supply would limit aerobic 
respiration for the supply of energy [113]. 
Another way in which control of infection may be aided by honey is through the 
ability of honey to prevent attachment of bacteria to cells. It has been reported that 
exposure of Salmonella interitidis to an 11 % solution of honey for 1 h prior to mixing 
the washed bacteria with intestinal epithelial cens decreased the number of bacteria 
attaching to the cells by 74% [114]. Honey, at concentrations as low as 0.00025%, has 
also been found to block the PAIIL lectin of P. aern.ginosa, which mediates biofilm 
formation and adhesion to animal cells by this species of bacteria (115J. It has been 
found that biofilm formation by P. aeruginosa and by a coagulase-negative Staphylo-
coccus is almost completely prevented by honey at a concentration of only 20% of its 
MIC [1161. 
9.S 
Clinical Uses of Honey as an Antimicrobial Agent 
The major usage of honey for control of infection has been in wound care [2], but 
there are reports in the modern medical literature of its successful use in ophthal-
mology and gastroenterology (see below), and of its effectiveness in a tria] on 
gingivitis [117]. With the reporting that inhalation of an aerosol of a 60% solution 
of honey causes no adverse effects [118], there is also the possi.bility of using honey for 
treatment of bronchial infections. 11le author is aware of anecdotal reports of such 
therapy being effective, also of honey being effective in the treatment of infection of 
the nasal sinuses and the ear canal, and for the treatment of tineas. These are 
applications which warrant further research. 
Although the antimicrobial activity of honey is ample for control of infection where 
the honey is in direct contact with the site ofinfection and does not get excessively 
diluted by body fluids, there would be far too much dilution to achieve anywhere near 
the MIC systemically even if the antimicrobial factors entered the circulation from the 
gut. However, within the gut it is feasible that a bolus of honey passing through from 
oral dosage would retain a concentration in excess of the MIC for gut pathogens. TIle 
results from a trial where mortality rates from induced infection of mice with E. coli 
0157:H7 and Salmonella typhimurium were substantially decreased by daily subcuta-
neous injection of 1 ml honey is more likely to be due to the honey stimulating the 
immune response than from a systemic direct antibacterial activity because the 
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dilution into the 25 g of body mass of the mouse would have given a concentration 
below the MI C for these pathogens for all but the most potent of the honeys they used. 
Honey given at a concentration of5 % (v Iv) in place of glucose in a rehydration fluid 
was found to give a statistically significant reduction in the duration of bacterial 
diarrhea (58 versus 93 h), and give no increase in the duration of nonbacterial 
diarrhea in a clinical trial conducted on infants and children admitted into hospital 
with gastroenteritis [119]. In a clinical trial in which 4S patients with dyspepsia were 
given no medication other than honey substantial reductions were found to result in 
the number of patients passing blood (from peptic ulcers) in their feces, the number 
with dyspepsia and the number with gastritis, duodenitis or a duodenal ulcer seen on 
endoscopy [120]. However, this action of honey may not be by way of its antibacterial 
activity, as it was found in a clinical trial that it failed to clear Helicobacterpylori [121.J. It 
appears to be more likely that it is the anti-inflammatory activity of honey (see below), 
rather than its antibacterial activity, that is involved in its beneficial effects on gastritis. 
A series of publications on biochemical studies on induced gastric ulcers in rats have 
pointed to the effect of honey to be via reduction of inflammation; this has been 
reviewed by Molan [122]. 
The anti-inflammatory activity of honey is probablY a contributing factor in the 
effectiveness of honey in ophthalmological applications, besides control oHnfection. 
Improvement was reported in 85% of the cases, with no deterioration in any of the 
other, in a trial of honey on 102 patients with a variety of ophthalmological disorders 
not responding to conventional treatment, such as keratitis, conjunctivitis and 
blepharitis [123]. Remission in more than 60% of the cases was reported where 
honey was used to treat blepharitis, catarrhal conjunctivitis, and keratitis [124]. A 
review of the use of honey in ophthalmology in Russia [1.25] describes anti-inflam-
matory, antibacterial and antifungal actions being seen, honey being used for 
chemica1 and thermal burns to the eye, conjunctivitis and infections of the cornea. 
A transient stinging sensation and redness of the eye soon after putting honey in the 
eye have been reported, but never enough to stop the treatment [123, 126]. A similar 
effect is experienced by some patients when honey is used to treat inflamed wounds 
and this has been attributed to the acidity of honey [2]. 
9.6 
Clinical Evidence for Effectiveness of Honey on Infected Wounds 
The very large body of clinical evidence for the effectiveness of honey in heaHng 
wounds has been reviewed [1271, The evidence covered in that review, plus that from 
trials published since the review was published [128-134], is from 23 randomized 
controlled trials involving a total of 2257 participants, seven clinical trials of other 
forms involving 142 participants treated with honey, four case studies where there 
were multiple wounds allowing comparison of honey with other treatment and 16 
trials of honey on a total of 533 wounds in animal models (which rule out a placebo 
effect). Mostly the wounds involved were infected. Where details were given in the 
reports about the clearance of infection by honey these are listed in Table 9.3. 
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Table 9.3 Reported details of clearance of infection in wounds 
when the wounds were dressed with honey. 
Type of wound 
Superficial burns 
Fresh partial"thiclcness burns 
Superficial burns 
Moderate burns, Ij6th total 
burn area being full thickness 
Superficial burns 
Severe postoperative wound 
infections following abdominal 
surgery 
Fournier's gangrene (necrotizing 
fasciitis on the scrotum) 
Large infected surgicaJ wounds 
on infants 
Multiple chronic leg ulcers, 
on both legs 
Outcome of honey treatment 
91% of wounds treated with honey 
became sterile within 7 days with 
honey, compared with 7% treated 
with silver sulfadiazine 
eight cases infected after 8 days with honey, 
compared with 17 treated with OpSite 
honey gave, better control of infection 
than silver sulfadiazine did 
after 7 days of honey treatment the 
original 44 cases giving positive swab 
cultures decreased to four, but with 
silver sulfadiazine there was no change 
in the 42 cases giving positive swab 
cultures at the start 
honey gave better control of infection 
mean time to get negative swab 
cultures was 6 days with honey 
treatment compared with 14.8 days 
with washing with 70% ethanol then 
applying pOVidone-iodine 
within 1 week with honey aU swabs 
were negative: there was no need 
to change from the routine antibiotics 
to ones to which the bacteria were 
found to be sensitive 
with honey treatment, marked dinical 
improvement was seen in all cases 
after 5 days, and all wounds were 
closed, clean and sterile after 21 days; 
whereas the wounds had failed to 
heal with treatment of at least 14 days 
using intravenous antibiotics 
(vancomycin plus cefotaxime, 
subsequently changed according 
to bacterial sensitivity), fusidic acid 
ointment, and wound cleaning with 
aqueous 0.05% chlorhexidine solution 
after 10 days of dreSSing the ulcers with 
honey signs of infection had cleared and 
the green exudate had ceased, whereas 
with the ulcers dressed vrith Aquacell 
there was copious leakage of green Huid, 
Reference 
[135] 
[Jl6] 
[106[ 
[137J 
[138] 
[139] 
[100] 
[108J 
[140] 
Table 9.3 (Continued) 
Type of wound 
Recalcitrant wounds and 
ulcers of varied etiology 
Broken-down wounds from 
radical vulvectomy 
with lymphadectomy 
Surgical wounds. mostly 
dehiscent or infected 
Disrupted abdominal wounds 
from Caesarean section 
9,7 
Resistant Bacteria 
9.7 Resistant Bacteria 1247 
Outcome of honey treatment 
no signs of healing in 1-24 months 
of conventional treatment (such as 
Eusol toilet and dressings of Acriflavine, 
Sofra-Tulle or Cicatrin, or systemk 
and topical antibiotics), but after honey 
treatment the 51 wounds with bacteria 
present became sterile within 1 week and 
the others remained sterile; burn wounds 
treated early healed q ukkly, not 
becoming colonized by bacteria. 
wounds became free from bacteria 
in 3-6 days 
wounds became sterile within 1-4- days, on 
patients with profound immunosuppression 
because of chemotherapy 
wounds were made sterile within 1 week 
Reference 
[lOlJ 
[99J 
[141] 
[102J 
--_._-,,---_.-
Because of its high osmolarity honey is not a medium in which bacteria could survive 
and thus have evolved genes for resistance by selection of mutant individuals with 
genes conferring resistance to the antibacterial factors that are effective in diluted 
honey. The period in which bacteria could live and have strains multiply during the 
production of honey in the hive would be short; then the selectively bred surviving 
bacterial strains would be terminated by prolonged exposure to high osmolarity. In a 
study designed to select for resistant mutants, by continuous exposure of cultures of 
P. aernginosa and S. aureus to increasing concentrations of an antibacterial agent, no 
increased resistance to honey was developed yet under the same experimental 
conditions marked increases in resistance to antibiotics were developed [116]. 
Similar resistance training experiments with manuka honey and several wound 
pathogens are being conducted elsewhere, but have not yet succeeded in recovering 
honey-resistant bacteria (R. Cooper, University of Wales Institute, personal 
communication). 
Owing to the increasing problem of bacteria almost inevitably developing resis-
tance to antibi.otics where these are extensively used, the low probability of resistance 
to honey developing makes the use of honey an attractive alternative for topical 
control of infection. As an example, although the incidence of catheter-associated 
blood-stTeam infections in dialysis patients with honey-treated catheter exit sites was 
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found in a trial [142J to be a bit higher than in those treated with mupirocin (0.97 
versus 0.85 episodes per 1000 catheter-days, not significantly different), the low 
likelihood of selecting for resistant strains of bacteria using honey compared with the 
high likelihood with continuous use of mupirocin makes the use of honey for 
chemoprophylaxis in patients with central venous catheters a better option. 
With most life-threatening infections with antibiotic-resistant bacteria being 
acquired by bacteria entering the bloodstream via catheters or open wounds, there 
is potential for preventing cross-infection in hospitals with antibiotic-resistant strains 
ofhacteria, by dressing all open wounds or catheter exit sites with honey. As well as 
the trial mentioned above there has been another trial which also has shown honey to 
be effective in chemoprophylaxis in patients with central venous catheters [143J. In 
this, the incidence of bloodstream infections in dialysis patients with honey-treated 
exit sites was found to be a bit lower than in those treated with povidone· iodine (12 
versus 19 episodes per 1000 ca'lh,eter-days, not significantly different). With wounds, 
the reports of cases where honey was effective in clearing established infection with 
MRSA and vancomycin-resistant Enterococcus (VRE) [lAO, 141, 144-148J indicate that 
it is likely to be effective prophylactically. If such an approach to infection control were 
tried, even ifitwere not successful it would at least give the best healing conditions for 
the wounds because of the other features of honey which promote wound healing. 
9.8 
Benefits Apart from Control of Infection in Topical Treatment with Honey 
Apart from its antibacterial activity honey has a potent anti-inflammatory activity, 
rapidly brings about autolytic debridement of slough and necroti.c tissue from 
wounds, rapidly deodorizes malodorous wounds, speeds up the healing process, 
and gives healing with minimal scarring: references to the many reports of observa-
tions of these features are given by Molan [149J. Antiseptics in common use are all 
cytotoxic and so slow the healing process [150J. Silver also is cytotoxic [151J and can 
cause poisoning systemically when absorbed from wound dressings [151]. Honey, 
however, is not only not toxic, but actually stimulates the growth of cells involved in 
wound healing [152-154J and stimulates the production of the components of the 
extracellular matrix [155. 156J. 
As is so aptly stated about honey by the Muslim prophet Mohammed (around 
570-632 AD) in verse 69 of Surah 16 ('The bee') of the Holy Qu'ran; 'From its belly 
cometh forth a fluid of varying hues, wherein there is healing for mankind'. 
9.9 
Future Directions 
More research is needed to obtain further data on the sensitivity to honeys with 
standardized activity of some of the multiresistant infecting species of bacteria 
which infect wounds and catheter exit sites, such as ADinetobacter baumanii and 
References 1249 
Stenotrophomonas ma-ltophilia. There is also a need for research to find the sensitivity 
to honeys with standardized activity of untested species which cause ophthalmic, 
bronchial and gut infections, to establish if clinical treatment of such infections with 
honey is worth trying. Good clinical trials are needed to establish with certainty how 
effective honey is for treating such infections. There is also a need for more good 
clinical trials to be conducted on honey as a treatment for chronic infected wound s, as 
much of the large body of work that has been done to date has been can-ied out on 
acute wounds and/or has had some defects in the design ofthe trials. There is also a 
need to measure in these trials the effectiveness of honey in clearing infection, as 
many of the h'ials conducted so far have assessed healing rather than specifically 
assessing clearance of infection, but the healing may have resulted from other 
bioactivities of the honey such as the anti-inflammatory and debriding actions and 
the stimulation of growth of repair tissues. 
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